Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteolysis | 6 | 2024 | 189 | 1.350 |
Why?
|
| Drug Discovery | 5 | 2024 | 179 | 1.310 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2024 | 616 | 0.850 |
Why?
|
| Gold | 1 | 2022 | 55 | 0.740 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 44 | 0.740 |
Why?
|
| Casein Kinase Ialpha | 1 | 2021 | 4 | 0.730 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 14 | 0.730 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2021 | 53 | 0.710 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 103 | 0.710 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 363 | 0.700 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 216 | 0.660 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 12 | 0.660 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2020 | 53 | 0.640 |
Why?
|
| Autophagy | 1 | 2023 | 423 | 0.610 |
Why?
|
| Proteins | 1 | 2023 | 1026 | 0.550 |
Why?
|
| Small Molecule Libraries | 3 | 2024 | 135 | 0.540 |
Why?
|
| Contraceptive Agents, Male | 2 | 2024 | 37 | 0.390 |
Why?
|
| Signal Transduction | 1 | 2022 | 4664 | 0.320 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 704 | 0.320 |
Why?
|
| Binding Sites | 2 | 2022 | 1203 | 0.300 |
Why?
|
| Transcription Factors | 3 | 2024 | 2436 | 0.240 |
Why?
|
| Triazoles | 2 | 2024 | 143 | 0.220 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2024 | 50 | 0.210 |
Why?
|
| Contraception | 1 | 2024 | 62 | 0.200 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 3671 | 0.200 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2021 | 83 | 0.200 |
Why?
|
| Humans | 17 | 2024 | 131318 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 99 | 0.180 |
Why?
|
| Ligands | 2 | 2022 | 486 | 0.180 |
Why?
|
| Piperidones | 1 | 2021 | 10 | 0.180 |
Why?
|
| Enzyme Activation | 1 | 2022 | 588 | 0.170 |
Why?
|
| Oxygen | 1 | 2024 | 552 | 0.170 |
Why?
|
| Oncogene Proteins | 1 | 2021 | 135 | 0.160 |
Why?
|
| DNA | 2 | 2022 | 1444 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 302 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 111 | 0.160 |
Why?
|
| Kinetics | 1 | 2021 | 1101 | 0.160 |
Why?
|
| Protein Kinases | 1 | 2020 | 322 | 0.150 |
Why?
|
| Cell Division | 1 | 2020 | 725 | 0.150 |
Why?
|
| Proteome | 1 | 2020 | 285 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2024 | 579 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 823 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1397 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2020 | 1569 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 765 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 454 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 1227 | 0.120 |
Why?
|
| Genomics | 1 | 2023 | 1625 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2464 | 0.110 |
Why?
|
| Molecular Structure | 2 | 2024 | 319 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1808 | 0.090 |
Why?
|
| Mutation | 1 | 2022 | 6177 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2967 | 0.060 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 14 | 0.050 |
Why?
|
| Azepines | 1 | 2024 | 62 | 0.050 |
Why?
|
| Carbon | 1 | 2024 | 93 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 442 | 0.050 |
Why?
|
| Palladium | 1 | 2022 | 20 | 0.050 |
Why?
|
| Semen | 1 | 2022 | 85 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 413 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2024 | 808 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 238 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 90 | 0.040 |
Why?
|
| Benzylamines | 1 | 2021 | 22 | 0.040 |
Why?
|
| Protein Domains | 1 | 2022 | 249 | 0.040 |
Why?
|
| Ikaros Transcription Factor | 1 | 2021 | 35 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2024 | 1087 | 0.040 |
Why?
|
| Oncogenes | 1 | 2021 | 164 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 1624 | 0.040 |
Why?
|
| Thalidomide | 1 | 2021 | 40 | 0.040 |
Why?
|
| Databases, Protein | 1 | 2020 | 63 | 0.040 |
Why?
|
| Protein Binding | 1 | 2024 | 1710 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 286 | 0.040 |
Why?
|
| Quinazolines | 1 | 2021 | 181 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 238 | 0.040 |
Why?
|
| Female | 3 | 2022 | 70975 | 0.040 |
Why?
|
| Tyrosine | 1 | 2019 | 148 | 0.040 |
Why?
|
| Lysine | 1 | 2019 | 175 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 309 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 635 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 604 | 0.030 |
Why?
|
| Male | 4 | 2024 | 65064 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2019 | 443 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 18468 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2604 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2568 | 0.030 |
Why?
|
| Animals | 2 | 2024 | 34324 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 10074 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 28780 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 31597 | 0.010 |
Why?
|